Strategic Acquisition of Intellectual Property of BRII-179, a Wholly Owned Phase 2b Asset Capable of Combining with Multiple HBV Treatment Modalities for Cure Data from Multiple Ongoing Late-Stage ...
[Audio Gap] Please be advised that today's call is being recorded. This call will be conducted in English. This is Kathy Yu, Associate Director of Investor Relations. Welcome to Brii Bio's 2025 Full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results